Peter Marks MD, PhD Director, Center for Biologics Evaluation and Research (CBER) Food and Drug Administration (FDA)
Tal Salz PhD Cell and Gene Therapy Reviewer, Office of Tissues and Advanced Therapies Division of Cellular and Gene Therapies Food and Drug Administration (FDA)/CBER
John Balchunus Workforce Director National Institute for Innovation in Manufacturing Biopharmaceuticals (NIIMBL)
Dan Bright Director Of Manufacturing Operations Cellectis
Shana Hardy Biologist, Office of Tissues and Advanced Therapies Division of Clinical Evaluation and Pharm/Tox FDA/CBER
John Tomtishen Director of Manufacturing, Technical Operations Legend Biotech
The browser you are using is not supported that will prevent you from accessing certain features of the website. We want you to have the best possible experience. For this you'll need to use a supported browser and upgrade to the latest version.